Skye is limitless

Unlocking the pharmaceutical potential of cannabinoids

We are a pharmaceutical company developing proprietary cannabinoid derivatives to treat glaucoma and other diseases

Our focus is on applying the well-established rigor of pharmaceutical drug development to a new class of therapeutics that target diseases in a safe and effective manner.


Driven by science and results, we see the untapped opportunities ahead

Our team shares the experience, expertise, commitment, and passion for advancing our unique and proprietary molecules from discovery through commercialization.